Involvement of mixed lineage kinase 3 in cancer¹

Author：

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.91, Iss.4, 2012-12, pp. : 268-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mixed Lineage Kinase Family, Potential Targets for Preventing Neurodegeneration

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 2, Iss. 2, 2002-06 ,pp. : 143-155

Bentham Science Publishers

Access to resources Recommend Favorite

The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 22, 2011-07 ,pp. : 2264-2277

Bentham Science Publishers

Access to resources Recommend Favorite

Oxygen-independent Regulation of HIF-1: Novel Involvement of PI3K/ AKT/mTOR Pathway in Cancer

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 245-251

Bentham Science Publishers

Access to resources Recommend Favorite

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

By Fujino H. Regan J.W.

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 335-340

Elsevier

Access to resources Recommend Favorite

New phosphatidylinositol 3-kinase inhibitors for cancer

By Bowles Daniel W Jimeno Antonio

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 507-518

Informa Healthcare

Access to resources Recommend Favorite